VANGUARD GROUP INC - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q2 2024$566,270
-17.7%
244,0820.0%0.00%
Q1 2024$688,311
-11.3%
244,0820.0%0.00%
Q4 2023$776,181
-0.1%
244,082
+3.7%
0.00%
Q3 2023$776,942
-0.6%
235,437
-0.6%
0.00%
Q2 2023$781,994
-0.3%
236,9680.0%0.00%
Q1 2023$784,364
-8.3%
236,9680.0%0.00%
Q4 2022$855,455
-59.2%
236,968
+0.0%
0.00%
Q3 2022$2,097,000
+15.0%
236,9150.0%0.00%
Q2 2022$1,824,000
-18.5%
236,915
-0.5%
0.00%
Q1 2022$2,238,000
+35.6%
238,1080.0%0.00%
Q4 2021$1,650,000
-27.4%
238,108
-0.4%
0.00%
Q3 2021$2,274,000
-4.4%
239,029
+0.5%
0.00%
Q2 2021$2,379,000
-14.5%
237,898
-0.0%
0.00%
Q1 2021$2,784,000
-65.7%
237,953
+4.6%
0.00%
Q4 2020$8,122,000
+165.3%
227,464
+2.7%
0.00%
Q3 2020$3,062,000
-17.6%
221,547
-1.7%
0.00%
Q2 2020$3,717,000
+201.9%
225,391
+55.7%
0.00%
Q1 2020$1,231,000144,7410.00%
Other shareholders
LUMOS PHARMA INC shareholders Q2 2024
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$14,540,0002.80%
Opaleye Management Inc. 281,287$10,045,0001.31%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$33,435,0000.66%
NEA Management Company, LLC 526,663$18,807,0000.50%
Investors Financial Group, LLC 18,200$650,0000.43%
One68 Global Capital, LLC 5,855$209,0000.42%
Wealth Advisors of Iowa, LLC 11,760$420,0000.26%
Blackstone Inc. 468,145$16,717,0000.06%
Foster Group, Inc. 7,283$221,0000.04%
Texas Yale Capital Corp. 16,000$571,0000.04%
View complete list of LUMOS PHARMA INC shareholders